I bought some, since I finally think 'profitability' has gone from an empty promise (next year, next year, next year) to reasonably achievable.
Revenue looks to be down 2% for Q3FY17 vs Q3FY16, Though in the report they said "We again grew revenues" - odd.
The table on page 2 of the report looks good - Q3 beat H1 on all metrics, bringing them close to the short-mid term goal, which would make the company profitable in the $70-$90m revenue range.
In FY16, Q3 and Q4 had similar revenue. If that holds true for Q4 FY17, then revenue would be $68m for the year, getting close to profitable, assuming the other metrics can continue to improve a little more.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
I bought some, since I finally think 'profitability' has gone...
Featured News
Add TPW (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.75 |
Change
-0.080(0.68%) |
Mkt cap ! $1.396B |
Open | High | Low | Value | Volume |
$11.88 | $12.02 | $11.66 | $1.785M | 151.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 585 | $11.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.77 | 1538 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 585 | 11.680 |
1 | 585 | 11.670 |
1 | 585 | 11.650 |
2 | 2585 | 11.630 |
1 | 3000 | 11.290 |
Price($) | Vol. | No. |
---|---|---|
11.770 | 1538 | 1 |
11.790 | 585 | 1 |
11.810 | 585 | 1 |
11.830 | 1585 | 2 |
11.850 | 585 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
TPW (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online